Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB.

Proceedings of the National Academy of Sciences of the United States of America2018Yan R, Zhang J, Park HJ, et al.

Study designOther primary literature

SubjectAnimal

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

AnimalsBrainCaffeineCoffeeDisease Models, AnimalFatty AcidsLewy Body DiseaseMiceMice, Inbred C57BLMice, TransgenicNeuronsNeuroprotectionParkinson DiseasePhosphorylationProtein Phosphatase 2Serotoninalpha-Synuclein

DOI 10.1073/pnas.1813365115

PMID 30509990

View source →